Results 91 to 100 of about 39,541 (234)

Nonhormone therapies for vasomotor symptom management

open access: yesCleveland Clinic Journal of Medicine
Vasomotor symptoms (VMS) are associated with adverse health consequences and can cause significant morbidity for postmenopausal women. Although hormone therapy remains the gold standard of VMS treatment in menopausal women, some women have contraindications to or may choose not to take hormone therapy.
Tara K, Iyer   +2 more
openaire   +2 more sources

Paced Respiration for Vasomotor and Other Menopausal Symptoms: A Randomized, Controlled Trial [PDF]

open access: yes, 2013
poster abstractBackground: Paced respiration has been internationally recommended for vasomotor symptoms (e.g., hot flashes, night sweats) despite limited empirical evidence.
Burns, Debra S.   +4 more
core  

Serum Estradiol Concentrations With Estradiol 0.06% Gel in Transgender and Gender‐Diverse Adults

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objective Transgender and gender‐diverse individuals undergoing estradiol therapy for gender affirmation are typically treated with oral or transdermal estradiol, with transdermal estradiol recommended for those aged > 45 years. There are limited data evaluating estradiol gel in gender‐affirming hormone therapy regimens. We aimed to assess the
Raquel A. Maggacis   +2 more
wiley   +1 more source

Potential role of gabapentin and extended- release gabapentin in the management of menopausal hot flashes

open access: yesInternational Journal of General Medicine, 2013
Manisha Yadav, Judith Volkar Center for Specialized Women’s Health, Cleveland Clinic Foundation, Cleveland, Ohio, USA Abstract: About 80% of postmenopausal women experience vasomotor symptoms, such as hot flashes and night sweats – symptoms ...
Yadav M, Volkar J
doaj  

Long-term experience of vasomotor instability: A five-year follow-up study of perceived control, coping and distress [PDF]

open access: yes, 2002
Objectives: Vasomotor instability can be a long-term feature of the post-menopause yet little is known about how women cope. This study followed up a group of women over five years, to examine whether current levels of flush-related distress/discomfort ...
Reynolds, F
core  

Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need [PDF]

open access: yes, 2018
The diagnostic management of patients with angina pectoris typically centres on the detection of obstructive epicardial CAD, which aligns with evidence-based treatment options that include medical therapy and myocardial revascularisation.
Berry, Colin   +2 more
core   +1 more source

Lifestyle Management in Menopause: A Systematic Review of Women With Premature Ovarian Insufficiency

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objective Premature ovarian insufficiency (POI), the loss of ovarian function before age 40, increases the risk of cardiovascular disease, low bone mineral density, dementia and psychological distress. Lifestyle interventions reduce chronic disease risk in other populations and, with hormone therapy, may improve health outcomes in POI.
Ladan Yeganeh   +4 more
wiley   +1 more source

COMPARISON OF VASOMOTOR SYMPTOMS IN POSTMENOPAUSAL WOMEN WITH DIFFERENT SOCIO-ECONOMIC STATUS

open access: yesGomal Journal of Medical Sciences, 2014
Background: Menopause is the permanent cessation of menstruation resulting from loss of ovarian follicular activity. The diagnosis of menopause can usually be ascertained from vasomotor symptoms and prolonged episode of amenorrhea. Many factors including
Shandana Bawar   +3 more
doaj  

Relationships between CYP2D6 phenotype, breast cancer and hot flushes in women at high risk of breast cancer receiving prophylactic tamoxifen: results from the IBIS-I trial [PDF]

open access: yes, 2012
Licensed under a Creative Commons Attribution Non-Commercial Share Alike ...
A Howell   +31 more
core   +1 more source

Cardiovascular Health in Women—Across the Lifespan

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy